• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ⅢA型黏多糖贮积症(A型Sanfilippo综合征)自然病程的评分评估

Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A).

作者信息

Meyer Ann, Kossow Kai, Gal Andreas, Mühlhausen Chris, Ullrich Kurt, Braulke Thomas, Muschol Nicole

机构信息

University Medical Center Hamburg-Eppendorf, Metabolic Center, Department of Pediatrics, Martinistrasse 52, Building N23, 20246 Hamburg, Germany.

出版信息

Pediatrics. 2007 Nov;120(5):e1255-61. doi: 10.1542/peds.2007-0282. Epub 2007 Oct 15.

DOI:10.1542/peds.2007-0282
PMID:17938166
Abstract

OBJECTIVE

Mucopolysaccharidosis types IIIA through IIID (Sanfilippo syndrome) are caused by deficiencies of enzymes involved in the degradation of heparan sulfate. The onset and severity of the disease are highly variable. The purpose of this study was to describe the natural course of mucopolysaccharidosis type IIIA in a large cohort of patients.

PATIENTS AND METHODS

The natural course of mucopolysaccharidosis type IIIA was assessed in 71 patients by using a detailed questionnaire and a 4-point scoring system and compared with the course of the disease in 14 patients with mucopolysaccharidosis type IIIB and 4 patients with mucopolysaccharidosis type IIIC.

RESULTS

In the cohort of patients with mucopolysaccharidosis type IIIA, first symptoms of disease were observed, on average, at 7 months of age. Speech and motor development were delayed in 66.2% and 33.9% of patients, respectively. The median age at diagnosis was 4.5 years. The onset of regression in speech, motor, and cognitive function was observed at an average age of 3.3 years. The loss of all 3 of the assessed abilities was observed at an average age of 12.5 years. Speech was lost before motor and cognitive functions. In a small group of patients who were >12.5 years of age (9.9%), speech, motor, and cognitive skills were partially preserved up to a maximum age of 23.8 years.

CONCLUSIONS

To our knowledge, this is the first systematic and comprehensive study on the natural course of mucopolysaccharidosis type IIIA. The 4-point scoring system may be used to classify patients into groups with a rapid or slower course of the disease. This may have an important impact on parental counseling as well as therapeutic interventions.

摘要

目的

ⅢA型至ⅢD型黏多糖贮积症(Sanfilippo综合征)是由参与硫酸乙酰肝素降解的酶缺乏引起的。该病的发病和严重程度差异很大。本研究的目的是描述一大群ⅢA型黏多糖贮积症患者的自然病程。

患者与方法

通过详细问卷和4分评分系统对71例ⅢA型黏多糖贮积症患者的自然病程进行评估,并与14例ⅢB型黏多糖贮积症患者和4例ⅢC型黏多糖贮积症患者的病程进行比较。

结果

在ⅢA型黏多糖贮积症患者队列中,疾病的首发症状平均在7个月大时出现。分别有66.2%和33.9%的患者出现言语和运动发育迟缓。诊断时的中位年龄为4.5岁。言语、运动和认知功能衰退的起始平均年龄为3.3岁。所有三项评估能力丧失的平均年龄为12.5岁。言语在运动和认知功能之前丧失。在一小群年龄大于12.5岁(9.9%)的患者中,言语、运动和认知技能部分保留,最大年龄为23.8岁。

结论

据我们所知,这是第一项关于ⅢA型黏多糖贮积症自然病程的系统全面研究。4分评分系统可用于将患者分为疾病进展快或慢的组。这可能对家长咨询以及治疗干预产生重要影响。

相似文献

1
Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A).ⅢA型黏多糖贮积症(A型Sanfilippo综合征)自然病程的评分评估
Pediatrics. 2007 Nov;120(5):e1255-61. doi: 10.1542/peds.2007-0282. Epub 2007 Oct 15.
2
The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome).硫酸酰胺酶基因(SGSH)中的p.Ser298Pro突变与ⅢA型粘多糖贮积症(Sanfilippo A综合征)的缓慢进展临床表型相关。
Hum Mutat. 2008 May;29(5):770. doi: 10.1002/humu.20738.
3
Mucopolysaccharidosis type III (Sanfilippo disease) in Sweden: clinical presentation of 22 children diagnosed during a 30-year period.黏多糖贮积症 III 型(Sanfilippo 病)在瑞典:30 年间 22 名确诊患儿的临床表现。
Acta Paediatr. 2010 Aug;99(8):1253-7. doi: 10.1111/j.1651-2227.2010.01800.x. Epub 2010 Mar 14.
4
Spinal muscular atrophy: survival pattern and functional status.脊髓性肌萎缩症:生存模式与功能状态
Pediatrics. 2004 Nov;114(5):e548-53. doi: 10.1542/peds.2004-0668. Epub 2004 Oct 18.
5
Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.通过对ⅢA型黏多糖贮积症患者培养成纤维细胞中乙酰肝素-N-硫酸酯酶进行免疫定量分析预测Sanfilippo综合征的表型严重程度
Mol Genet Metab. 2001 Aug;73(4):306-12. doi: 10.1006/mgme.2001.3190.
6
Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B.土耳其的桑菲利波综合征:A 型和 B 型亚型中新突变的鉴定。
Hum Mutat. 2002 Feb;19(2):184-5. doi: 10.1002/humu.9009.
7
Sanfilippo syndrome type D: natural history and identification of 3 novel mutations in the GNS Gene.D型桑菲利波综合征:自然病史及GNS基因中3个新突变的鉴定
Arch Neurol. 2007 Nov;64(11):1629-34. doi: 10.1001/archneur.64.11.1629.
8
Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems?当你看到患有智力障碍和行为问题的成年人时,你会联想到B型Sanfilippo综合征吗?
Am J Med Genet C Semin Med Genet. 2007 Aug 15;145C(3):293-301. doi: 10.1002/ajmg.c.30142.
9
Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome).Ⅲ型黏多糖贮积症(Sanfilippo综合征)的临床及神经放射学随访
Neuropediatrics. 1999 Oct;30(5):270-4. doi: 10.1055/s-2007-973503.
10
An observational, prospective, multicenter, natural history study of patients with mucopolysaccharidosis type IIIA.黏多糖贮积症 IIIA 型患者的观察性、前瞻性、多中心、自然史研究。
Mol Genet Metab. 2022 Feb;135(2):133-142. doi: 10.1016/j.ymgme.2021.12.002. Epub 2021 Dec 10.

引用本文的文献

1
The Role of the Gut Microbiota in Sanfilippo Syndrome's Physiopathology: An Approach in Two Affected Siblings.肠道微生物群在 Sanfilippo 综合征发病机制中的作用:两例患病同胞的研究方法。
Int J Mol Sci. 2024 Aug 14;25(16):8856. doi: 10.3390/ijms25168856.
2
Increased pituitary volumes in patients with Sanfilippo syndrome (mucopolysaccharidosis type 3, MPS III).Sanfilippo综合征(黏多糖贮积症III型,MPS III)患者垂体体积增大。
Neuroradiology. 2023 Sep;65(9):1381-1386. doi: 10.1007/s00234-023-03157-2. Epub 2023 May 2.
3
Mucopolysaccharidosis type IIIC in chinese mainland: clinical and molecular characteristics of ten patients and report of six novel variants in the HGSNAT gene.
中国大陆黏多糖贮积症 IIIC 型:10 例患者的临床和分子特征及 HGSNAT 基因 6 个新变异的报告。
Metab Brain Dis. 2023 Aug;38(6):2013-2023. doi: 10.1007/s11011-023-01204-8. Epub 2023 Apr 4.
4
Sanfilippo syndrome: consensus guidelines for clinical care.黏多糖贮积症 Sanfilippo 综合征:临床护理共识指南。
Orphanet J Rare Dis. 2022 Oct 27;17(1):391. doi: 10.1186/s13023-022-02484-6.
5
Natural History and Molecular Characteristics of Korean Patients with Mucopolysaccharidosis Type III.韩国黏多糖贮积症III型患者的自然病史及分子特征
J Pers Med. 2022 Apr 21;12(5):665. doi: 10.3390/jpm12050665.
6
Caregivers' assessment of meaningful and relevant clinical outcome assessments for Sanfilippo syndrome.护理人员对桑菲利波综合征有意义且相关的临床结局评估的评价
J Patient Rep Outcomes. 2022 Apr 25;6(1):40. doi: 10.1186/s41687-022-00447-w.
7
Seven-year follow-up of durability and safety of AAV CNS gene therapy for a lysosomal storage disorder in a large animal.大型动物溶酶体贮积症的腺相关病毒中枢神经系统基因治疗的耐久性和安全性的七年随访
Mol Ther Methods Clin Dev. 2021 Oct 5;23:370-389. doi: 10.1016/j.omtm.2021.09.017. eCollection 2021 Dec 10.
8
Gastrointestinal Manifestations in Mucopolysaccharidosis Type III: Review of Death Certificates and the Literature.Ⅲ型黏多糖贮积症的胃肠道表现:死亡证明及文献综述
J Clin Med. 2021 Sep 27;10(19):4445. doi: 10.3390/jcm10194445.
9
Disease Manifestations in Mucopolysaccharidoses and Their Impact on Anaesthesia-Related Complications-A Retrospective Analysis of 99 Patients.黏多糖贮积症的疾病表现及其对麻醉相关并发症的影响——99例患者的回顾性分析
J Clin Med. 2021 Aug 10;10(16):3518. doi: 10.3390/jcm10163518.
10
An Engineered Mutant Zebrafish Recapitulates Molecular and Behavioural Pathobiology of Sanfilippo Syndrome A/MPS IIIA.工程化突变斑马鱼重现了黏多糖贮积症 IIIA 型(Sanfilippo 综合征 A/MPS IIIA)的分子和行为病理生物学特征。
Int J Mol Sci. 2021 May 31;22(11):5948. doi: 10.3390/ijms22115948.